Brilinta: More likely to kill you than prevent a heart attack
May 26, 2015 – Drug giant AstraZeneca has quietly asked the FDA to dramatically expand the market for its controversial blood thinner Brilinta. And that will put even more people at risk of bleeding to death... Read More >


